BioAdvance: Detailed Company Information & Corporate Profile
Summary
BioAdvance is a investment company that has been in the industry for 23 years. The company currently specializes in the Biotechnology area. The position of the CEO is occupied by Barbara Schilberg. Its headquarters is located at Philadelphia, Pennsylvania, USA. The number of employees ranges from 1 to 25. The annual revenue of BioAdvance varies between 1 and 10M. To connect with BioAdvance employee register on SignalHire.
| BioAdvance Website | bioadvance.com |
| Social Links |  |
| Phone Number | 610-230-0544 |
| Industries | |
| Company Size | 1-10 employees |
| SIC Code | 6411, 6199 |
| DMA Code | Delaware Valley |
| Founded | 06/2003 |
| Estimated Annual Revenue | $1 - 10M |
| Operating Status | Independent Company |
Competitors
Name | Founded | Type | Employees | Revenue | Funding |
|---|---|---|---|---|---|
| 2011 | Public Company | 25 - 100 | 602.7K | $4.7M | |
| 2014 | Privately Held | 25 - 100 | 3.6M | $40.6M | |
| 2019 | Privately Held | 10-50 | 17.9M | $- | |
| 2016 | - | 10-50 | 32.7M | $- |
Workforce Turnover
Length of Employment
BioAdvance's workforce includes employees across a wide range of tenure levels.
10% have been with the company for 1 to 2 years5% have been with the company for 3 to 4 years10% have been with the company for 5 to 7 years15% have been with the company for 8 to 10 years60% have been with the company for more than 11 years
Email (4)
Phone (2)Email (4)Phone (2)Phone (1)Email (3)Phone (1)Email (2)Phone (1)
Companies Similar to BioAdvance
BioAdvance Corporate Information: FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
